Effect of D609 on CCL2 secretion induced by R5 AT-2–inactivated HIV-1 in MDMs
Treatments . | CCL2, pg/mL . | ||
---|---|---|---|
Donor 1 . | Donor 2 . | Donor 3 . | |
None | 5362 | 1230 | 3452 |
R5 AT-2-HIV-1 | 11 328 | 3416 | 15 254 |
D609 | 3790 | 875 | 1970 |
D609+ R5 AT-2-HIV-1 | 5760 | 1150 | 3520 |
Treatments . | CCL2, pg/mL . | ||
---|---|---|---|
Donor 1 . | Donor 2 . | Donor 3 . | |
None | 5362 | 1230 | 3452 |
R5 AT-2-HIV-1 | 11 328 | 3416 | 15 254 |
D609 | 3790 | 875 | 1970 |
D609+ R5 AT-2-HIV-1 | 5760 | 1150 | 3520 |
Monocytes were seeded in 96-well cluster plates (2×105 cells/0.2 mL per well). After 7 days, culture medium was removed and replaced with 0.2 mL fresh medium. MDMs were pretreated with D609 (50 μg/mL) or left untreated. After 30 minutes, some cultures were exposed to R5 AT-2–inactivated viruses (17 ng HIVp24gag/106 cells). After 24 hours of culture, supernatants were harvested and frozen before CCL2 determination. Data are the mean values of duplicate samples. The intersample variability did not exceed 10%.